Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metis TechBio Co's book value per share for the quarter that ended in Dec. 2025 was €0.11.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
Metis TechBio Co's current price is €1.311. Its book value per share for the quarter that ended in Dec. 2025 was €0.11. Hence, today's PB Ratio of Metis TechBio Co is 11.92.
During the past 4 years, the highest P/B Ratio of Metis TechBio Co was 21.74. The lowest was 10.08. And the median was 13.15.
Metis TechBio Co (FRA:RO9) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Metis TechBio Co Book Value per Share Related Terms
Metis TechBio Co Book Value per Share Historical Data
* Premium members only.
The historical data trend for Metis TechBio Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metis TechBio Co Book Value per Share Chart
Metis TechBio Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Book Value per Share
-0.01
-0.11
-0.16
0.11
Metis TechBio Co Quarterly Data
Dec22
Dec23
Dec24
Sep25
Dec25
Book Value per Share
-0.01
-0.11
-0.16
0.12
0.11
FRA:RO9 vs VRTX, REGN, RVMD: Book Value per Share Comparison
For the Biotechnology subindustry, Metis TechBio Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metis TechBio Co PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Metis TechBio Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Metis TechBio Co's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metis TechBio Co (FRA:RO9) has a Book Value per Share of €0.11 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Metis TechBio Co and its competitors.
Is Metis TechBio Co's Book Value per Share too high?
Metis TechBio Co's current Book Value per Share is €0.11. Overall, Metis TechBio Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's Book Value per Share compare to VRTX and REGN?
Metis TechBio Co's Book Value per Share of €0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Metis TechBio Co and its competitors. Metis TechBio Co's current Book Value per Share is €0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (FRA:RO9) has a current Book Value per Share of €0.11. The current Book Value per Share is €0.11. Metis TechBio Co's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Metis TechBio Co (FRA:RO9), the current Book Value per Share is €0.11 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
17GF Score
Get the complete analysis for FRA:RO9
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RO9 has been successfully added to your 
